Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Making a Connection: The State of Cybersecurity for Industrial Networks

Industrial networks are under threat from cyberattacks. On Feb. 8, Oldsmar, Florida, announced a cyber intrusion into its water treatment system. They detected the attack, but only after network infiltration. David Zaveski, Product Manager at Antaira, spoke about the threats to industrial networks, what makes it easy to infiltrate them, and what IT departments…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Making a Connection: The State of Cybersecurity for Industrial Networks

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Industrial networks are under threat from cyberattacks. On Feb. 8, Oldsmar, Florida, announced a cyber intrusion into its water treatment system. They detected the attack, but only after network infiltration.

David Zaveski, Product Manager at Antaira, spoke about the threats to industrial networks, what makes it easy to infiltrate them, and what IT departments can do to prevent such attacks.

Zaveski’s previous roles included working with enterprise networks, and this background gave him a lot of experience in understanding the importance of keeping networks secure. This experience is something he wants to bring to industrial networks, too.

“Industrial networks are quite different from enterprise networks,” Zaveski said. “They are required to have quicker responses across networks, but many are unprotected.”

Many industrial networks are protected from outside cyber interference through “air gapping” their networks by restricting connectivity from the outside. This provides a sense of protection from cyberthreats. And Zaveski said that does protect them. So, why are there breaches?

“What happens is, at some point, another somebody gets the idea that they want to be able to monitor the system remotely, and I want to connect that data and publish it for later planning,” he said. “As soon as they do that and attach that network to the public network, or internet, [risk is there].”

Now, a pathway to infiltrating that once-protected industrial network is created, and the cybersecurity risks begin.

Protocols and devices deployed across a network can keep them more secure. Still, any organization’s most important step is to restrict network access to just what individuals and devices need it, not carte blanche accessibility.

“Look at your network, and say, ‘I know I have A, B, C devices, and I know that A needs to communicate with B and C, but B and C never need to communicate with each other. So, I should block all traffic going from B to C.’ That’s great,” Zaveski said. “Because, now, if somebody hacks in at B, at least they can’t get to C.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512